Rien Broekstra
Partner
Brinkhof
Farnaz Massoumian
Senior Patent Attorney
Vodafone
Jessica Kaplan
Head of Legal & Compliance
Deugro Group
Klaus Moosmayer
Member of the Supervisory Board
Deutsche Bank
Barbara Badoino
Head of Corporate Ethics, Risk & Compliance
Novartis
Aviva Cohen
Chief Compliance Officer
Swisscard
This 10 minute presentation will provide you with an exploration of how illicit compounding intersects with
patent protections, market exclusivity, and the proposed EU pharma package revisions shaping the future of
pharmaceutical innovation.
Raquel Frisardi
Associate Corporate Counsel
Novo Nordisk
Gisbert Hohagen
Partner
Taylor Wessing